Psychosis after ultrarapid opiate detoxification.
Shreeram
S S
SS
McDonald
T
T
Dennison
S
S
D000525:Alprazolam / Q000009:adverse effects / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006853:Hydrocodone / Q000627:therapeutic use; D008691:Methadone / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D013997:Time Factors
D001569:Benzodiazepines; D006853:Hydrocodone; D008691:Methadone; D000525:Alprazolam